BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11213967)

  • 41. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
    Jack AM; Aydin N; Montenegro G; Alam K; Wallack M
    J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes.
    Musiani P; Modesti A; Brunetti M; Modica A; Vitullo P; Gulino A; Bosco MC; Colombo MP; Nanni P; Cavallo F
    Nat Immun; 1994; 13(2-3):93-101. PubMed ID: 8173240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant immunotherapy using fibroblasts genetically engineered to secrete interleukin 12 prevents recurrence after surgical resection of established tumors in a murine adenocarcinoma model.
    Matsumoto G; Sunamura M; Shimamura H; Kodama T; Hashimoto W; Kobari M; Kato K; Takeda K; Yagita H; Okumura K; Hamada H; Matsuno S
    Surgery; 1999 Mar; 125(3):257-64. PubMed ID: 10076609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunity to growth factor receptor-bound protein 10, a signal transduction molecule, inhibits the growth of breast cancer in mice.
    O-Sullivan I; Chopra A; Carr J; Kim TS; Cohen EP
    Cancer Res; 2008 Apr; 68(7):2463-70. PubMed ID: 18381455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens.
    Kim TS; Russell SJ; Collins MK; Cohen EP
    Int J Cancer; 1992 May; 51(2):283-9. PubMed ID: 1533203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunity to breast cancer in mice immunized with fibroblasts transfected with a cDNA expression library derived from small numbers of breast cancer cells.
    Sung Kim T; Cohen EP
    Cancer Gene Ther; 2005 Nov; 12(11):890-9. PubMed ID: 15905859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
    Negri DR; Mezzanzanica D; Sacco S; Gadina M; Benigni F; Cajola L; Finocchiaro G; Ghezzi P; Canevari S
    Cytokine; 2001 Jul; 15(1):27-38. PubMed ID: 11509006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats.
    Graf MR; Merchant RE
    J Neurooncol; 1999; 45(3):209-18. PubMed ID: 10845391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.
    Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF
    Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-tumor effect of murine renal cell carcinoma cells genetically modified to express B7-1 combined with cytokine secreting fibroblasts.
    Wang J; Nakamoto T; Kasaoka Y; Usui T; Hamada H
    Hiroshima J Med Sci; 2000 Mar; 49(1):73-82. PubMed ID: 10824460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection against experimental cerebral metastases of murine melanoma B16 by active immunization.
    Staib L; Harel W; Mitchell MS
    Cancer Res; 1993 Mar; 53(5):1113-21. PubMed ID: 8439956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retroviral-mediated IL-2 gene transfer into murine neuroblastoma.
    Cho HS; Song JY; Park CY; Lyu CJ; Kim BS; Kim KY
    Yonsei Med J; 2000 Feb; 41(1):76-81. PubMed ID: 10731923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local IL-4 delivery enhances immune reactivity to murine tumors: gene therapy in combination with IL-2.
    Pippin BA; Rosenstein M; Jacob WF; Chiang Y; Lotze MT
    Cancer Gene Ther; 1994 Mar; 1(1):35-42. PubMed ID: 7621236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.
    Giovarelli M; Musiani P; Modesti A; Dellabona P; Casorati G; Allione A; Consalvo M; Cavallo F; di Pierro F; De Giovanni C
    J Immunol; 1995 Sep; 155(6):3112-23. PubMed ID: 7673726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I evaluation of interleukin-2-transfected irradiated allogeneic melanoma for the treatment of metastatic melanoma: appendix 1: protocol.
    Das Gupta TK; Cohen EP; Richards JM
    Hum Gene Ther; 1997 Sep; 8(14):1701-14. PubMed ID: 9322873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
    Larchian WA; Horiguchi Y; Nair SK; Fair WR; Heston WD; Gilboa E
    Clin Cancer Res; 2000 Jul; 6(7):2913-20. PubMed ID: 10914741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
    Addison CL; Bramson JL; Hitt MM; Muller WJ; Gauldie J; Graham FL
    Gene Ther; 1998 Oct; 5(10):1400-9. PubMed ID: 9930346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene therapy for murine renal cell carcinoma using genetically engineered tumor cells to secrete interleukin-12.
    Kasaoka Y; Nakamoto T; Wang J; Usui T; Hamada H
    Hiroshima J Med Sci; 2000 Mar; 49(1):29-35. PubMed ID: 10824454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.